FibroBiologics (NASDAQ: FBLG)
$0.49
(-3.6%)
-$0.02
Price as of October 9, 2025, 4:00 p.m. ET
FibroBiologics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
FibroBiologics Company Info
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.